BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6199637)

  • 1. Side-effects of antileprosy drugs in common use.
    Jopling WH
    Lepr Rev; 1983 Dec; 54(4):261-70. PubMed ID: 6199637
    [No Abstract]   [Full Text] [Related]  

  • 2. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drugs used in tuberculosis and leprosy].
    Aoyagi T; Toyoda T
    Nihon Rinsho; 1990 Oct; 48(10):2212-7. PubMed ID: 2280466
    [No Abstract]   [Full Text] [Related]  

  • 4. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR; Spencer TI; Ladizinski B
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
    Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
    Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
    Queiroz RH; Melchior Júnior E; de Souza AM; Gouveia E; Barbosa JC; de Carvalho D
    Pharm Acta Helv; 1997 Sep; 72(4):209-13. PubMed ID: 9372643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
    Singh H; Nel B; Dey V; Tiwari P; Dulhani N
    Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
    Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug therapy of leprosy.
    Ramu G
    Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
    [No Abstract]   [Full Text] [Related]  

  • 14. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia].
    Goulart IM; Arbex GL; Carneiro MH; Rodrigues MS; Gadia R
    Rev Soc Bras Med Trop; 2002; 35(5):453-60. PubMed ID: 12621663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
    Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
    Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and hematological side effects of clofazimine in leprosy patients.
    Costa Queiroz RH; de Souza AM; Sampaio SV; Melchior E
    Pharmacol Res; 2002 Aug; 46(2):191-4. PubMed ID: 12220960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.